NCT05709782

Brief Summary

To learn whether giving spinal stereotactic radiosurgery (SRSS) that uses a more advanced imaging scan method called Magnetic Resonance imaging with a Linear Accelerator (MR-LINAC) during treatment will lead to improved responses to treatment and better quality of life. SRSS is radiation therapy given to the area around your spine.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 2, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

May 9, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

January 14, 2026

Status Verified

January 1, 2026

Enrollment Period

2.7 years

First QC Date

January 24, 2023

Last Update Submit

January 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • M. D. Anderson Symptom Inventory - Spine Tumor (MDASI-SP) questionnaires

    M. D. Anderson Symptom Inventory - Spine Tumor (MDASI-SP) 0 (symptom has not been present) to 10 (the symptom was as bad as you can imagine it could be) for each item.

    through study completion; an average of 1 year

Study Arms (2)

Group 1 (Therapeutic Cohort)

EXPERIMENTAL

Participants in Group 1 will receive spine radiosurgery on the MR LINAC machine, along with imaging scans using the same machine.

Procedure: Spine RadiosurgeryDevice: Magnetic Resonance imagingRadiation: MR-LINAC

Group 2 (Imaging-only Cohort)

EXPERIMENTAL

Participants in Group 2 will receive spine radiosurgery using a standard radiation therapy machine and have the opportunity to get imaging on the MR LINAC.

Procedure: Spine RadiosurgeryDevice: Magnetic Resonance imaging

Interventions

scan

Group 1 (Therapeutic Cohort)Group 2 (Imaging-only Cohort)

scan

Group 1 (Therapeutic Cohort)Group 2 (Imaging-only Cohort)
MR-LINACRADIATION

scan

Group 1 (Therapeutic Cohort)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old
  • Radiographically documented disease of the spine within 4 weeks of registration (candidates with or without epidural disease allowed)
  • Candidate for spine SRS/SBRT as determined by treating Radiation Oncologist or Multidisciplinary Spine Conference review
  • Maximum of 3 contiguous vertebral levels involved with metastasis in the spine to be irradiated allowed
  • Diagnosis of cancer documented
  • Motor strength ≥ 4 out of 5 in the extremity affected by the level of spinal disease planned for radiation
  • Karnofsky Performance score (KPS) ≥ 40 or ECOG score ≤ 3

You may not qualify if:

  • Patients with highly radiosensitive histologies likely to respond to conventional radiation therapy alone (ie lymphoma, multiple myeloma, etc)
  • Patients who are unable to undergo MRI of the spine with contrast
  • Patients who are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Spinal Diseases

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Debra N. Yeboa, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Debra N. Yeboa, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2023

First Posted

February 2, 2023

Study Start

May 9, 2023

Primary Completion

January 31, 2026

Study Completion

January 31, 2026

Last Updated

January 14, 2026

Record last verified: 2026-01

Locations